
Restricted Stock Units: 6 Tax And Financial-Planning Strategies
Beware. When you receive a grant of restricted stock units (RSUs), do not make the mistake of thinking the tax and financial planning is simple. You recognize income and owe taxes on the shares' value when the stock is delivered at vesting—whether you're ready or not! Then, when you sell the shares, how long you kept them separately affects your capital gain or loss for taxes.
In a recent webinar that I moderated, three elite financial advisors who have extensive experience in planning with RSUs, stock options, and ESPPs discussed the various strategies and topics that they review with their clients. This article presents six of their insights.
1. RSU Vesting: Tax Withholding
For webinar panelist Travis Gatzemeier, the founder of Kinetix Financial Planning in the Dallas–Fort Worth area of Texas, tax awareness and planning are the starting points for clients with RSUs. Tax withholding is often the very first topic he discusses.
'The biggest thing I see with RSUs is under-withholding on taxes at vesting,' he stated. Companies withhold taxes on the income recognized at RSU vesting, but often the flat federal withholding rate used for this type of income is not enough to cover all the taxes you owe. The required federal rate is 22% up to $1 million in a calendar year and 37% for amounts in excess of that, though some companies now allow a rate election. 'Newer clients especially will come in wondering why they have such a big tax bill.'
'The primary thing that I help my RSU clients with is tax withholding,' concurred webinar panelist Valerie Gospodarek, the owner of VG Financial Consulting in the San Francisco Bay area in California. 'I can't tell you how many people are surprised that they have a large tax bill when they're doing their tax returns for the year. I help make sure they've held enough throughout the year. It does get a little challenging, especially if the stock price has been volatile.'
The higher the RSU income, the more likely it is that taxes on the income will be under-withheld at vesting, observed webinar panelist CJ Stermetz, the founder of the firm Equity For The Win in San Jose, California. If shares cannot be sold to cover the additional taxes, other ways to do so will have to be planned, he said.
One common method is quarterly estimated taxes. However, that's tricky if the prior year's income, on which estimated taxes are based, is very different to this year's income.
The best solution to avoid IRS and state underpayment penalties, Stermetz recommends, 'is to be sure we're running quarterly tax projections or talking with a CPA to keep on track with the safe harbor for federal taxes during the year.'
2. Questions For RSU Planning
RSUs, with their fixed vesting schedules, often seem simple relative to the more complex planning around stock option exercise strategies. However, Stermetz warned that this appearance can be deceptive.
'There's a lot of organization and a lot of details that can go wrong,' Stermetz warned. That is why it's important for him to understand clients' situations long before the specifics of tax planning come into play. These include any intention they may have to move states during the vesting period, which then raises separate mobility tax issues; and dates for ESPP purchases, stock option exercises, and RSU vestings that can cause wash sale issues for company stock sold at a loss.
He noted several questions that he talks through with clients:
Stermetz revealed that the issue of concentration in company stock is sometimes particularly difficult, not least because the client's spouse may not even be aware of the concentration level and the related financial risk.
'I see it all the time that a client is busy working crazy hours at a tech company and has amassed a ton of wealth, but the spouse has no idea that their entire livelihood depends on the performance of this one company's stock,' he said.
3. Reducing Income In Years RSUs Vest
Both Stermetz and Gatzemeier explained how you can plan around the RSU income to reduce your overall tax hit beyond just harvesting capital losses. They discussed many ways to do this to lower your other taxable income in a vesting year. Ideas to consider include:
4. Decisions At Vesting: Hold Or Sell?
Once you own the shares, you must decide whether to hold them or sell them. Gospodarek said she routinely advises her clients to sell RSU shares as soon as they receive them at vesting, 'before the price has a chance to fluctuate a lot.' This is particularly a concern, she asserted, for clients who already have a lot of wealth concentrated in holdings of company stock. 'There's just no need to take on more risk with that stock.'
Gatzemeier said that he guides his clients through the decision about how many shares to hold and how many to sell after RSU vesting—but the decision that clients reach is often the same. 'A lot of times for my clients it is selling immediately to use those proceeds to deploy toward other areas of their financial lives,' he said.
5. Trading Windows Impact Selling Plans
A selling plan for RSUs usually depends heavily on company trading windows, when employees are allowed to sell shares of company stock. That is a big piece of the RSU organization puzzle, said Stermetz.
'When we say 'sell your RSUs at vesting' we don't necessarily mean sell literally when they vest,' clarified Stermetz, building on what Gatzemeier and Gospodarek noted about hold/sell decisions at RSU vesting. 'We mean 'sell when you are able to sell them' according to the company trading windows,' along with the others rules to prevent insider trading and any Rule 10b5-1 trading plan you may have. It's important for clients to know that, for example, shares which vest on January 1 may not be sellable until February 1, he said.
'Typically trading windows will happen after an earnings call, and the window is usually four to six weeks,' observed Stermetz. 'You can't necessarily know all the dates exactly for a whole year, but you can estimate according to what's been done in the past.' Stermetz then takes the client's RSU vesting schedule for the year and compares it to the set of company trading windows for stock sales that the client is likely to have.
6. RSU Taxes As A Financial-Planning Motivator
While advisors generally tell clients that taxes should not be the primary driver of investment decisions, Stermetz finds that the exigency of paying taxes can make it easier to advise a client to sell company stock from an overly concentrated position.
'Sometimes for clients who are afraid to sell a concentrated position, having a tax rationale for why they should sell is a really good incentive to sell that stock,' he revealed. 'If they're under-withheld and need to sell some of that stock to pay their tax bill, they will be willing to do it.' That, in turn, can help the client stick to a plan of regular sales of shares acquired from RSU vestings.
Gatzemeier echoed the importance of anticipation about taxes and concentrated positions with RSUs, especially in a volatile stock market. 'You really can't do much financial planning until you have done a tax-awareness exercise so you know what's left.' If you eventually realize you have to sell stock to pay extra taxes on RSU income but by then the stock price has declined significantly, you're in a lurch. 'It's a bad experience for a client if the taxes are not planned out well ahead of time.'
Further Resources On Restricted Stock Units
The webinar in which these advisors spoke is available on demand at the myStockOptions Webinar Channel. More advisor views on RSU planning are available through articles from financial planners in the section Restricted Stock Units at myStockOptions.com, which also has RSU planning tools and courses.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
LivePerson Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, July 25, 2025 /PRNewswire/ -- LivePerson, Inc. (Nasdaq: LPSN) is providing confirmatory notice, in compliance with the requirements of Nasdaq Listing Rule 5635(c)(4), of recent grants of equity-based incentive awards that LivePerson made under the LivePerson Inc. 2018 Inducement Plan (the "Inducement Plan"). LivePerson established the Inducement Plan for the purpose of providing equity-based incentive awards to new hires and has done so during active periods of hiring. As such, LivePerson made grants under the Inducement Plan on various dates in connection with recent employee hirings which occurred during the first quarter of 2025. In July, LivePerson granted inducement awards to newly hired employees consisting of 1 grant of restricted stock units ("RSUs") in respect of an aggregate of 16,000 shares of LivePerson's common stock. In May, LivePerson granted inducement awards consisting of 2 grants of RSUs in respect of an aggregate of 51,000 shares of common stock. In April and June, LivePerson granted no inducement awards. These RSUs will vest 50% per year over 2 years, subject to each grantee's continued employment over the scheduled vesting date. All of the RSUs are subject to the grantee's continued employment on the scheduled vesting date. Each RSU award that was granted under the Inducement Plan was granted as an inducement that was material to the grantee's entering into employment with LivePerson. About LivePerson, (NASDAQ: LPSN) is a leader in trusted enterprise conversational AI and digital transformation. The world's leading brands — including HSBC, Virgin Media and Chipotle — use our award-winning Conversational Cloud platform to connect with millions of consumers. We power nearly a billion conversational interactions every month, providing uniquely rich data analytics and safety tools to unlock the power of conversational AI for better business outcomes. Fast Company named LivePerson the #1 Most Innovative AI Company in the world. Learn more at Investor Contact: ir-lp@ View original content to download multimedia: SOURCE LivePerson, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Associated Press
6 days ago
- Associated Press
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ('DiagnaMed' or the 'Company') is pleased to announce that, in accordance with its equity incentive plan, it has issued a total of 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants of the Company. The RSUs and options were granted as part of DiagnaMed's ongoing efforts to align the interests of its leadership and key partners with those of shareholders, and to reward contributions to the Company's continued growth and development. The 2,500,000 stock options have an exercise price of $0.05 per share and are exercisable for a period of three (3) years from the date of grant. All RSUs and options are subject to the terms and conditions of the Company's equity incentive plan and applicable regulatory approvals. These grants reflect the Board's confidence in the strategic direction of the Company, particularly as it advances its natural hydrogen projects in Ontario alongside its collaborative partners, INRS and QIMC. This initiative underscores DiagnaMed's commitment to driving innovation and growth in the natural hydrogen sector in Ontario. The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario. About DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit For more information, please contact: John Karagiannidis, President and CEO DiagnaMed Holdings Corp. Tel: 514-726-7058 Email: [email protected] Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as 'will', 'may', 'expect', 'could', 'can', 'estimate', 'anticipate', 'intend', 'believe', 'projected', 'aims', and 'continue' or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption 'Risk Factors' in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ('MD&A'), dated May 28, 2025, which is available on the Company's profile at Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the '1933 Act') or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. To view the source version of this press release, please visit
Yahoo
6 days ago
- Yahoo
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is pleased to announce that, in accordance with its equity incentive plan, it has issued a total of 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants of the Company. The RSUs and options were granted as part of DiagnaMed's ongoing efforts to align the interests of its leadership and key partners with those of shareholders, and to reward contributions to the Company's continued growth and development. The 2,500,000 stock options have an exercise price of $0.05 per share and are exercisable for a period of three (3) years from the date of grant. All RSUs and options are subject to the terms and conditions of the Company's equity incentive plan and applicable regulatory approvals. These grants reflect the Board's confidence in the strategic direction of the Company, particularly as it advances its natural hydrogen projects in Ontario alongside its collaborative partners, INRS and QIMC. This initiative underscores DiagnaMed's commitment to driving innovation and growth in the natural hydrogen sector in Ontario. The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario. About DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit For more information, please contact: John Karagiannidis, President and CEO DiagnaMed Holdings Corp. Tel: 514-726-7058 Email: info@ Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as "will", "may", "expect", "could", "can", "estimate", "anticipate", "intend", "believe", "projected", "aims", and "continue" or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ("MD&A"), dated May 28, 2025, which is available on the Company's profile at Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. To view the source version of this press release, please visit